Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

xCures · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
bladder cancer, urothelial carcinoma, transitional cell carcinoma, platinum-resistant urothelial carcinoma, bladder urothelial carcinoma, fgfr mutation, fgfr2 gene mutation, fgfr3 gene mutation, fgfr2 amplification, locally advanced urothelial carcinoma, metastatic urothelial carcinoma, refractory bladder carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 825816
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.